Therapy Modality: Continuous Ambulatory Peritoneal Dialysis (CAPD)

Slides:



Advertisements
Similar presentations
RENAL REPLACEMENT THERAPY
Advertisements

Acute Renal Replacement Therapy for the Infant Dr.Fahad Gadi, MD Pediatrics Demonstrator King Abdulaziz University Rabigh Medical School.
Acute Renal Replacement Therapy for the Infant Dr.Fahad Gadi, MD Pediatrics Demonstrator King Abdulaziz University Rabigh Medical School.
Fresenius Medical Care Peritoneal Dialysis Connections
Dialysis: A Thermodynamic Perspective Alyssa Chang, Austin Dosch, Meredith Greeson, Carrie Martin, Bobby Palmer.
PERITONEAL DIALYSIS Continuous Kathy Bunyan Ambulatory November 2011 Peritoneal Dialysis.
Outline the problems that arise from kidney failure and discuss the use of renal dialysis and transplants for the treatment of kidney failure Kidney failure.
1 Peritoneal Dialysis (PD) Principles Peritoneum Fluid and Solute Removal PD Fluid Treatment modes CAPD/APD Complications Treatment Strategy.
Peritoneal dialysis Dr Ejaz Ahmed.
Renal Replacement Therapy (RRT)
Dr. Leonid Feldman Nephrology and Hypertension Division Assaf Harofeh Medical Center November, 2007 Peritoneal Dialysis.
Treatment Options for End Stage Kidney Disease Dr Vipula De Silva.
Urgent-Start Peritoneal Dialysis Cathy Wilson-Bates, RN, CDN, CPDN.
Renal Replacement Therapy: What the PCP Needs to Know.
AWAK- Automated Wearable Artificial Kidney
Related material to renal diseases Dr. May Hamdan 1 st course 2013/2014.
Chronic Kidney Disease Treatment Options
Peritoneal Dialysis Adequacy & Prescription Management
Will Peritoneal Dialysis Modality Make a Difference in Peritonitis? Reference: Piraino B, Sheth H. Peritonitis – Does peritoneal dialysis modality make.
Reference Avram MM, et al. Hemoglobin predicts long-term survival in dialysis patients: a 15-year single-center longitudinal study and a correlation trend.
RENAL REPLACEMENT THERAPY
Therapy Modality: Automated Peritoneal Dialysis (APD)
Peritoneal Dialysis PD Access. Peritoneal Dialysis Peritoneal Catheters  PD catheter is patients lifeline  Several advances have made access safer and.
Anatomy and Physiology of Peritoneal Dialysis
Complications of Dialysis
Peritoneal Dialysis. Source of information neal/
CHAPTER 12 Peritoneal Dialysis Sunita Bavanandan Lily Mushahar Anita Bhajan Manocha Source: 20 th MDTR Report 2012, NRR.
Outcome of patients started on PD as first line therapy, Saira Usama, Jamal S. Alwakeel, Ahmad H. Mitwalli, Abdulkareem Alsuwaida, Akram Askar, King Khalid.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PERITONEAL DIALYSIS CHAPTER 6.
PERITONEAL MEMBRANE CHARACTERISTICS IN SAUDI PATIENTS Prof. Jamal Alwakeel, Dr Saira Usama Dr Abdulkareem Alsuwaida, Dr Mohammad AL Ghonaim, Dr Akram.
Fresenius Medical Care Peritoneal Dialysis Connections
James Heaf Herlev Hospital University of Copenhagen
Renal Medicine David Johnson Princess Alexandra Hospital Brisbane, Australia A Comparison of APD vs CAPD on Patient Outcomes A Comparison of APD vs CAPD.
Principles and Techniques of Dialysis. Introduction 2 basic techniques – haemo or peritoneal Several refinements within these Haemo –Dialysis –Filtration.
Prescription of pediatric peritoneal dialysis
Renal Replacement Therapy (RRT) Types of therapy available to patients who have failing kidneys Debbie Jones RN CNeph(C)
Home Haemodialysis: Improving Patient Safety
Chapter 5 Peritoneal Dialysis 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Peritoneal.
“Adequacy in PD prescription What, How, When?
’10 slides on peritoneal dialysis in older CKD patients’
© ANZDATA Registry Stock and Flow of CAPD Patients Australia Number of Patients 1504 Patients * (Data to 30 Sept) Extrapolated.
Principles of Peritoneal Dialysis
NIPEC Annual Conference Professional Standards Enhancing Person-Centred Care Assisted Automated Peritoneal Dialysis(aAPD) Susie Mawhinney PD Nurse BCH.
Creative marketing strategies can drive significant financial returns Please turn your audio on.
Complications of PD Peter Rutherford Medical Director Senior Lecturer in Nephrology.
신장내과 이지연 Peritoneal dialysis-related infection ISPD guidelines 2010 update.
Fungal Peritonitis (FP) Constantinos J. Stefanidis “P. and A. Kyriakou” Children’s Hospital Athens, Greece.
Bloods – it’s all about blood.
Acid-base profile in patients on PD
Nephrology Specialist at New Mansoura General Hospital
Taking basic physiology to the clinic!
West Midlands Renal Peer Review
The ADEMEX Trial Adequacy of PD in Mexico Reference
Principles of dialysis
The CANUSA Trial Reference
CHAPTER 6 PERITONEAL DIALYSIS Fiona Brown Aarti Gulyani
Annie-Claire Nadeau-Fredette
Acid-base profile in patients on PD
Nephrology Skills Laboratory
Study sample selection process.
Kariah Healthcare Solutions
Volume 64, Pages S3-S12 (December 2003)
Incremental peritoneal dialysis: Effects on the choice of dialysis modality, residual renal function and adequacy  G. Viglino, L. Neri, S. Barbieri  Kidney.
Pancreas Program Functional Inactivity
Glucose sparing in peritoneal dialysis: Implications and metrics
Ali K. Abu-Alfa, John Burkart, Beth Piraino, Joe Pulliam, Salim Mujais 
Volume 73, Issue 4, Pages (February 2008)
Volume 78, Issue 6, Pages (September 2010)
Benefits of preserving residual renal function in peritoneal dialysis
ANZDATA Peritoneal Dialysis Report
Presentation transcript:

Therapy Modality: Continuous Ambulatory Peritoneal Dialysis (CAPD) Renal Division Baxter Healthcare

CAPD - basic prescription Manual therapy Prescription volumes standardised 1,500ml, 2000ml, 2500ml, 3000ml solution bags 6-8 hour dwell period each night (depends on type of membrane) 4-5 day exchanges (with optional night dwell), 7 days a week 3-5 hr dwell per day exchange

CAPD Exchange Procedure 1. Fill phase (<10 Minutes)

CAPD Exchange Procedure 2. Dwell phase (4-8 hours) 3. Drain phase (<20 minutes)

CAPD CAPD Optimum dialysis for low permeability Continuous Therapy Volume Benefits Limitations 24 Time Optimum dialysis for low permeability Can be performed anywhere High transporters will have poor UF 4 x exchanges per day IP pressure with large volumes Ambulatory Anywhere 4 - 5 Exchanges Long Dwells

Procedural Modifications - increasing UF 1 2 3

Procedural Modification - fill volume Increasing fill volumes maximises the peritoneal capacity and improves solute clearances. You will notice that the time between exchanges however does NOT change.

Procedural Modification - no. of exchanges By adding a 5th exchange will also improve solute clearances in patients who cannot tolerate higher fill volumes OR for those who need shorter dwell times (perhaps due to the type of peritoneal membrane identified on the PET test). In this example, the dwell time will shorten (compared to the previous example)

PD Technique Survival % Years Kawaguchi PDI 1999;19 (supp 2):S327 This slide just highlights that patient TECHNIQUE SURVIVAL (i.e. the time a patient stays on CAPD) on PD decreases steadily over time on PD. On average therefore, a patient will remain on PD for between 4-6 years. The trend is very similar across Europe. The objective therefore is to reduce the number of patients ‘dropping’ out of PD programmes over time, and there are several strategies one can use in this respect.

PD Technique Survival Reasons for withdrawal - Loss of UF Kawaguchi PDI 1999;19 (supp 2):S327 Reasons for withdrawal - Loss of UF - Inadequate dialysis - Peritonitis - Patient choice/psychological (‘burn-out’)

CAPD Outcome - Japan 235 patients analysed between 1980 - 1997 Kawaguchi PDI 1999;19 (suppl 3):S9 235 patients analysed between 1980 - 1997 Average survival was 5.8 years 142 patients changed dialysis therapy Causes - loss of UF (23%) - inadequate dialysis (16%) - peritonitis (14%) Peritonitis rate was very good - 1 episode/54 patient months

Causes of Technique Failure in Long-term PD 14% 5% 36% 20% 25%

CAPD Systems Requirements: Minimise risk of touch contamination AIM: Safety, Simplicity, Comfort & Convenience Requirements: Minimise risk of touch contamination Maximise Flush efficiency Inactivate organisms at patient connector if touch contamination occurred. Proven and reliable connectology Increased inactivation of organisms at the patient connection if a touch contamination occurs Easy to learn and use system for all patients

Improvements in PD Connectology Gokal R., Nolph K.: Textbook of PD: 1-15, 1994. 1 in 1 1 in 5 1 in 10 1 in 15 1 in 20 1 in 25 1 in 30 1 in 35 1 in 40 78 79 80 81 82 83 84 85 86 87 88 89 90 95 2000 1977-80 Data: Nolph & Sorkin, U. Missions 1980-87 Data: CAPD Registry, USA 1987-90 Data: Anecodotal reports, Europe/USA Infections (Per Patient Months) 1979: Monthly Tubing Change Titanium Adapter 1980: New Spike CAPD Set 1985: Extended Life Transfer Set, BDP 1986: UVXD 1986: APD-PAC X 1987: Y Set 1988: TwinBag - Europe 1989: UV-Flash, Pac Xtra 1990: PD Ultra Bag 1995: Homechoice 2000: Homechoice PRO

Peritonitis – Y-set Systems Holly AJKD 1994 > Peritonitis rates have improved over the years Straight line Y-set Staph epid. 0.34 0.17 Staph aureus 0.15 0.13 Gram -ve 0.12 0.10 Fungal 0.02 0.01 Peritonitis rate episodes/pt month disconnect O-set titaneum Plastic bags Glass bottles

Sources of Contamination Routes of entry

Safety: Reduced risk of organisms entering the PD system if touch contamination occurs Kubey W., et al., Blood Purification; 2000, 19(1). Twinbag connectology allows significantly (p<0.0001) fewer bacteria to be transferred into the fluid path. A recessed luer is of particular importance. Non-Recessed luer Recessed luer

CAPD Connectology: Reduced risk Kubey W., et al., Blood Purification; 2000, 19(1). The short distance between the Y-Junction and the patient connection ensures effective removal of bacterial contamination from the patient line should connection failure occur.